Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 2 minute read Pharma Industry News Novo Nordisk announces $11bn acquisition of fill-finish sites to boost global manufacturing In a strategic move to enhance its global manufacturing capabilities, Novo Nordisk has announced a significant acquisition from… byPallavi MadhirajuFebruary 5, 2024